Global Non-invasive Cancer Diagnosis Market Growth (Status and Outlook) 2022-2028
![](/report_cover/10189/global-non-invasive-cancer-diagnosis-market-growth-status-n-outlook-2022-2028_en.gif)
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Non-invasive Cancer Diagnosis will have significant change from previous year. According to our (LP Information) latest study, the global Non-invasive Cancer Diagnosis market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Non-invasive Cancer Diagnosis market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Non-invasive Cancer Diagnosis market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Non-invasive Cancer Diagnosis market, reaching US$ million by the year 2028. As for the Europe Non-invasive Cancer Diagnosis landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Non-invasive Cancer Diagnosis players cover Gen-Probe Inc., A&G Pharmaceutical, Affymetrix Inc., and Digene Corporation, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-invasive Cancer Diagnosis market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
As the global economy mends, the 2021 growth of Non-invasive Cancer Diagnosis will have significant change from previous year. According to our (LP Information) latest study, the global Non-invasive Cancer Diagnosis market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Non-invasive Cancer Diagnosis market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Non-invasive Cancer Diagnosis market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Non-invasive Cancer Diagnosis market, reaching US$ million by the year 2028. As for the Europe Non-invasive Cancer Diagnosis landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Non-invasive Cancer Diagnosis players cover Gen-Probe Inc., A&G Pharmaceutical, Affymetrix Inc., and Digene Corporation, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-invasive Cancer Diagnosis market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- Clinical Chemistry
- Immunochemistry/Immunoassay
- Molecular Diagnostics
- Others
- Blood Cancer
- Solid Tumors
- Breast Cancer
- Lung Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Gen-Probe Inc.
- A&G Pharmaceutical
- Affymetrix Inc.
- Digene Corporation
- Quest Diagnostics Inc.
- BioView Inc.
- LabCorp
- AVIVA Biosciences Corporation
- Precision Therapeutics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-invasive Cancer Diagnosis Market Size 2017-2028
2.1.2 Non-invasive Cancer Diagnosis Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Non-invasive Cancer Diagnosis Segment by Type
2.2.1 Clinical Chemistry
2.2.2 Immunochemistry/Immunoassay
2.2.3 Molecular Diagnostics
2.2.4 Others
2.3 Non-invasive Cancer Diagnosis Market Size by Type
2.3.1 Non-invasive Cancer Diagnosis Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Non-invasive Cancer Diagnosis Market Size Market Share by Type (2017-2022)
2.4 Non-invasive Cancer Diagnosis Segment by Application
2.4.1 Blood Cancer
2.4.2 Solid Tumors
2.4.3 Breast Cancer
2.4.4 Lung Cancer
2.4.5 Others
2.5 Non-invasive Cancer Diagnosis Market Size by Application
2.5.1 Non-invasive Cancer Diagnosis Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Non-invasive Cancer Diagnosis Market Size Market Share by Application (2017-2022)
3 NON-INVASIVE CANCER DIAGNOSIS MARKET SIZE BY PLAYER
3.1 Non-invasive Cancer Diagnosis Market Size Market Share by Players
3.1.1 Global Non-invasive Cancer Diagnosis Revenue by Players (2020-2022)
3.1.2 Global Non-invasive Cancer Diagnosis Revenue Market Share by Players (2020-2022)
3.2 Global Non-invasive Cancer Diagnosis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-INVASIVE CANCER DIAGNOSIS BY REGIONS
4.1 Non-invasive Cancer Diagnosis Market Size by Regions (2017-2022)
4.2 Americas Non-invasive Cancer Diagnosis Market Size Growth (2017-2022)
4.3 APAC Non-invasive Cancer Diagnosis Market Size Growth (2017-2022)
4.4 Europe Non-invasive Cancer Diagnosis Market Size Growth (2017-2022)
4.5 Middle East & Africa Non-invasive Cancer Diagnosis Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Non-invasive Cancer Diagnosis Market Size by Country (2017-2022)
5.2 Americas Non-invasive Cancer Diagnosis Market Size by Type (2017-2022)
5.3 Americas Non-invasive Cancer Diagnosis Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-invasive Cancer Diagnosis Market Size by Region (2017-2022)
6.2 APAC Non-invasive Cancer Diagnosis Market Size by Type (2017-2022)
6.3 APAC Non-invasive Cancer Diagnosis Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-invasive Cancer Diagnosis by Country (2017-2022)
7.2 Europe Non-invasive Cancer Diagnosis Market Size by Type (2017-2022)
7.3 Europe Non-invasive Cancer Diagnosis Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-invasive Cancer Diagnosis by Region (2017-2022)
8.2 Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Type (2017-2022)
8.3 Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-INVASIVE CANCER DIAGNOSIS MARKET FORECAST
10.1 Global Non-invasive Cancer Diagnosis Forecast by Regions (2023-2028)
10.1.1 Global Non-invasive Cancer Diagnosis Forecast by Regions (2023-2028)
10.1.2 Americas Non-invasive Cancer Diagnosis Forecast
10.1.3 APAC Non-invasive Cancer Diagnosis Forecast
10.1.4 Europe Non-invasive Cancer Diagnosis Forecast
10.1.5 Middle East & Africa Non-invasive Cancer Diagnosis Forecast
10.2 Americas Non-invasive Cancer Diagnosis Forecast by Country (2023-2028)
10.2.1 United States Non-invasive Cancer Diagnosis Market Forecast
10.2.2 Canada Non-invasive Cancer Diagnosis Market Forecast
10.2.3 Mexico Non-invasive Cancer Diagnosis Market Forecast
10.2.4 Brazil Non-invasive Cancer Diagnosis Market Forecast
10.3 APAC Non-invasive Cancer Diagnosis Forecast by Region (2023-2028)
10.3.1 China Non-invasive Cancer Diagnosis Market Forecast
10.3.2 Japan Non-invasive Cancer Diagnosis Market Forecast
10.3.3 Korea Non-invasive Cancer Diagnosis Market Forecast
10.3.4 Southeast Asia Non-invasive Cancer Diagnosis Market Forecast
10.3.5 India Non-invasive Cancer Diagnosis Market Forecast
10.3.6 Australia Non-invasive Cancer Diagnosis Market Forecast
10.4 Europe Non-invasive Cancer Diagnosis Forecast by Country (2023-2028)
10.4.1 Germany Non-invasive Cancer Diagnosis Market Forecast
10.4.2 France Non-invasive Cancer Diagnosis Market Forecast
10.4.3 UK Non-invasive Cancer Diagnosis Market Forecast
10.4.4 Italy Non-invasive Cancer Diagnosis Market Forecast
10.4.5 Russia Non-invasive Cancer Diagnosis Market Forecast
10.5 Middle East & Africa Non-invasive Cancer Diagnosis Forecast by Region (2023-2028)
10.5.1 Egypt Non-invasive Cancer Diagnosis Market Forecast
10.5.2 South Africa Non-invasive Cancer Diagnosis Market Forecast
10.5.3 Israel Non-invasive Cancer Diagnosis Market Forecast
10.5.4 Turkey Non-invasive Cancer Diagnosis Market Forecast
10.5.5 GCC Countries Non-invasive Cancer Diagnosis Market Forecast
10.6 Global Non-invasive Cancer Diagnosis Forecast by Type (2023-2028)
10.7 Global Non-invasive Cancer Diagnosis Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Gen-Probe Inc.
11.1.1 Gen-Probe Inc. Company Information
11.1.2 Gen-Probe Inc. Non-invasive Cancer Diagnosis Product Offered
11.1.3 Gen-Probe Inc. Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Gen-Probe Inc. Main Business Overview
11.1.5 Gen-Probe Inc. Latest Developments
11.2 A&G Pharmaceutical
11.2.1 A&G Pharmaceutical Company Information
11.2.2 A&G Pharmaceutical Non-invasive Cancer Diagnosis Product Offered
11.2.3 A&G Pharmaceutical Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 A&G Pharmaceutical Main Business Overview
11.2.5 A&G Pharmaceutical Latest Developments
11.3 Affymetrix Inc.
11.3.1 Affymetrix Inc. Company Information
11.3.2 Affymetrix Inc. Non-invasive Cancer Diagnosis Product Offered
11.3.3 Affymetrix Inc. Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Affymetrix Inc. Main Business Overview
11.3.5 Affymetrix Inc. Latest Developments
11.4 Digene Corporation
11.4.1 Digene Corporation Company Information
11.4.2 Digene Corporation Non-invasive Cancer Diagnosis Product Offered
11.4.3 Digene Corporation Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Digene Corporation Main Business Overview
11.4.5 Digene Corporation Latest Developments
11.5 Quest Diagnostics Inc.
11.5.1 Quest Diagnostics Inc. Company Information
11.5.2 Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Product Offered
11.5.3 Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Quest Diagnostics Inc. Main Business Overview
11.5.5 Quest Diagnostics Inc. Latest Developments
11.6 BioView Inc.
11.6.1 BioView Inc. Company Information
11.6.2 BioView Inc. Non-invasive Cancer Diagnosis Product Offered
11.6.3 BioView Inc. Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 BioView Inc. Main Business Overview
11.6.5 BioView Inc. Latest Developments
11.7 LabCorp
11.7.1 LabCorp Company Information
11.7.2 LabCorp Non-invasive Cancer Diagnosis Product Offered
11.7.3 LabCorp Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 LabCorp Main Business Overview
11.7.5 LabCorp Latest Developments
11.8 AVIVA Biosciences Corporation
11.8.1 AVIVA Biosciences Corporation Company Information
11.8.2 AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Product Offered
11.8.3 AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 AVIVA Biosciences Corporation Main Business Overview
11.8.5 AVIVA Biosciences Corporation Latest Developments
11.9 Precision Therapeutics
11.9.1 Precision Therapeutics Company Information
11.9.2 Precision Therapeutics Non-invasive Cancer Diagnosis Product Offered
11.9.3 Precision Therapeutics Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Precision Therapeutics Main Business Overview
11.9.5 Precision Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-invasive Cancer Diagnosis Market Size 2017-2028
2.1.2 Non-invasive Cancer Diagnosis Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Non-invasive Cancer Diagnosis Segment by Type
2.2.1 Clinical Chemistry
2.2.2 Immunochemistry/Immunoassay
2.2.3 Molecular Diagnostics
2.2.4 Others
2.3 Non-invasive Cancer Diagnosis Market Size by Type
2.3.1 Non-invasive Cancer Diagnosis Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Non-invasive Cancer Diagnosis Market Size Market Share by Type (2017-2022)
2.4 Non-invasive Cancer Diagnosis Segment by Application
2.4.1 Blood Cancer
2.4.2 Solid Tumors
2.4.3 Breast Cancer
2.4.4 Lung Cancer
2.4.5 Others
2.5 Non-invasive Cancer Diagnosis Market Size by Application
2.5.1 Non-invasive Cancer Diagnosis Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Non-invasive Cancer Diagnosis Market Size Market Share by Application (2017-2022)
3 NON-INVASIVE CANCER DIAGNOSIS MARKET SIZE BY PLAYER
3.1 Non-invasive Cancer Diagnosis Market Size Market Share by Players
3.1.1 Global Non-invasive Cancer Diagnosis Revenue by Players (2020-2022)
3.1.2 Global Non-invasive Cancer Diagnosis Revenue Market Share by Players (2020-2022)
3.2 Global Non-invasive Cancer Diagnosis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-INVASIVE CANCER DIAGNOSIS BY REGIONS
4.1 Non-invasive Cancer Diagnosis Market Size by Regions (2017-2022)
4.2 Americas Non-invasive Cancer Diagnosis Market Size Growth (2017-2022)
4.3 APAC Non-invasive Cancer Diagnosis Market Size Growth (2017-2022)
4.4 Europe Non-invasive Cancer Diagnosis Market Size Growth (2017-2022)
4.5 Middle East & Africa Non-invasive Cancer Diagnosis Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Non-invasive Cancer Diagnosis Market Size by Country (2017-2022)
5.2 Americas Non-invasive Cancer Diagnosis Market Size by Type (2017-2022)
5.3 Americas Non-invasive Cancer Diagnosis Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-invasive Cancer Diagnosis Market Size by Region (2017-2022)
6.2 APAC Non-invasive Cancer Diagnosis Market Size by Type (2017-2022)
6.3 APAC Non-invasive Cancer Diagnosis Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-invasive Cancer Diagnosis by Country (2017-2022)
7.2 Europe Non-invasive Cancer Diagnosis Market Size by Type (2017-2022)
7.3 Europe Non-invasive Cancer Diagnosis Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-invasive Cancer Diagnosis by Region (2017-2022)
8.2 Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Type (2017-2022)
8.3 Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-INVASIVE CANCER DIAGNOSIS MARKET FORECAST
10.1 Global Non-invasive Cancer Diagnosis Forecast by Regions (2023-2028)
10.1.1 Global Non-invasive Cancer Diagnosis Forecast by Regions (2023-2028)
10.1.2 Americas Non-invasive Cancer Diagnosis Forecast
10.1.3 APAC Non-invasive Cancer Diagnosis Forecast
10.1.4 Europe Non-invasive Cancer Diagnosis Forecast
10.1.5 Middle East & Africa Non-invasive Cancer Diagnosis Forecast
10.2 Americas Non-invasive Cancer Diagnosis Forecast by Country (2023-2028)
10.2.1 United States Non-invasive Cancer Diagnosis Market Forecast
10.2.2 Canada Non-invasive Cancer Diagnosis Market Forecast
10.2.3 Mexico Non-invasive Cancer Diagnosis Market Forecast
10.2.4 Brazil Non-invasive Cancer Diagnosis Market Forecast
10.3 APAC Non-invasive Cancer Diagnosis Forecast by Region (2023-2028)
10.3.1 China Non-invasive Cancer Diagnosis Market Forecast
10.3.2 Japan Non-invasive Cancer Diagnosis Market Forecast
10.3.3 Korea Non-invasive Cancer Diagnosis Market Forecast
10.3.4 Southeast Asia Non-invasive Cancer Diagnosis Market Forecast
10.3.5 India Non-invasive Cancer Diagnosis Market Forecast
10.3.6 Australia Non-invasive Cancer Diagnosis Market Forecast
10.4 Europe Non-invasive Cancer Diagnosis Forecast by Country (2023-2028)
10.4.1 Germany Non-invasive Cancer Diagnosis Market Forecast
10.4.2 France Non-invasive Cancer Diagnosis Market Forecast
10.4.3 UK Non-invasive Cancer Diagnosis Market Forecast
10.4.4 Italy Non-invasive Cancer Diagnosis Market Forecast
10.4.5 Russia Non-invasive Cancer Diagnosis Market Forecast
10.5 Middle East & Africa Non-invasive Cancer Diagnosis Forecast by Region (2023-2028)
10.5.1 Egypt Non-invasive Cancer Diagnosis Market Forecast
10.5.2 South Africa Non-invasive Cancer Diagnosis Market Forecast
10.5.3 Israel Non-invasive Cancer Diagnosis Market Forecast
10.5.4 Turkey Non-invasive Cancer Diagnosis Market Forecast
10.5.5 GCC Countries Non-invasive Cancer Diagnosis Market Forecast
10.6 Global Non-invasive Cancer Diagnosis Forecast by Type (2023-2028)
10.7 Global Non-invasive Cancer Diagnosis Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Gen-Probe Inc.
11.1.1 Gen-Probe Inc. Company Information
11.1.2 Gen-Probe Inc. Non-invasive Cancer Diagnosis Product Offered
11.1.3 Gen-Probe Inc. Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Gen-Probe Inc. Main Business Overview
11.1.5 Gen-Probe Inc. Latest Developments
11.2 A&G Pharmaceutical
11.2.1 A&G Pharmaceutical Company Information
11.2.2 A&G Pharmaceutical Non-invasive Cancer Diagnosis Product Offered
11.2.3 A&G Pharmaceutical Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 A&G Pharmaceutical Main Business Overview
11.2.5 A&G Pharmaceutical Latest Developments
11.3 Affymetrix Inc.
11.3.1 Affymetrix Inc. Company Information
11.3.2 Affymetrix Inc. Non-invasive Cancer Diagnosis Product Offered
11.3.3 Affymetrix Inc. Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Affymetrix Inc. Main Business Overview
11.3.5 Affymetrix Inc. Latest Developments
11.4 Digene Corporation
11.4.1 Digene Corporation Company Information
11.4.2 Digene Corporation Non-invasive Cancer Diagnosis Product Offered
11.4.3 Digene Corporation Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Digene Corporation Main Business Overview
11.4.5 Digene Corporation Latest Developments
11.5 Quest Diagnostics Inc.
11.5.1 Quest Diagnostics Inc. Company Information
11.5.2 Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Product Offered
11.5.3 Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Quest Diagnostics Inc. Main Business Overview
11.5.5 Quest Diagnostics Inc. Latest Developments
11.6 BioView Inc.
11.6.1 BioView Inc. Company Information
11.6.2 BioView Inc. Non-invasive Cancer Diagnosis Product Offered
11.6.3 BioView Inc. Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 BioView Inc. Main Business Overview
11.6.5 BioView Inc. Latest Developments
11.7 LabCorp
11.7.1 LabCorp Company Information
11.7.2 LabCorp Non-invasive Cancer Diagnosis Product Offered
11.7.3 LabCorp Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 LabCorp Main Business Overview
11.7.5 LabCorp Latest Developments
11.8 AVIVA Biosciences Corporation
11.8.1 AVIVA Biosciences Corporation Company Information
11.8.2 AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Product Offered
11.8.3 AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 AVIVA Biosciences Corporation Main Business Overview
11.8.5 AVIVA Biosciences Corporation Latest Developments
11.9 Precision Therapeutics
11.9.1 Precision Therapeutics Company Information
11.9.2 Precision Therapeutics Non-invasive Cancer Diagnosis Product Offered
11.9.3 Precision Therapeutics Non-invasive Cancer Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Precision Therapeutics Main Business Overview
11.9.5 Precision Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Non-invasive Cancer Diagnosis Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Clinical Chemistry
Table 3. Major Players of Immunochemistry/Immunoassay
Table 4. Major Players of Molecular Diagnostics
Table 5. Major Players of Others
Table 6. Non-invasive Cancer Diagnosis Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Non-invasive Cancer Diagnosis Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Non-invasive Cancer Diagnosis Market Size Market Share by Type (2017-2022)
Table 9. Non-invasive Cancer Diagnosis Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Non-invasive Cancer Diagnosis Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Non-invasive Cancer Diagnosis Market Size Market Share by Application (2017-2022)
Table 12. Global Non-invasive Cancer Diagnosis Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Non-invasive Cancer Diagnosis Revenue Market Share by Player (2020-2022)
Table 14. Non-invasive Cancer Diagnosis Key Players Head office and Products Offered
Table 15. Non-invasive Cancer Diagnosis Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Non-invasive Cancer Diagnosis Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Non-invasive Cancer Diagnosis Market Size Market Share by Regions (2017-2022)
Table 20. Americas Non-invasive Cancer Diagnosis Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Non-invasive Cancer Diagnosis Market Size Market Share by Country (2017-2022)
Table 22. Americas Non-invasive Cancer Diagnosis Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Non-invasive Cancer Diagnosis Market Size Market Share by Type (2017-2022)
Table 24. Americas Non-invasive Cancer Diagnosis Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Non-invasive Cancer Diagnosis Market Size Market Share by Application (2017-2022)
Table 26. APAC Non-invasive Cancer Diagnosis Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Non-invasive Cancer Diagnosis Market Size Market Share by Region (2017-2022)
Table 28. APAC Non-invasive Cancer Diagnosis Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Non-invasive Cancer Diagnosis Market Size Market Share by Type (2017-2022)
Table 30. APAC Non-invasive Cancer Diagnosis Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Non-invasive Cancer Diagnosis Market Size Market Share by Application (2017-2022)
Table 32. Europe Non-invasive Cancer Diagnosis Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Non-invasive Cancer Diagnosis Market Size Market Share by Country (2017-2022)
Table 34. Europe Non-invasive Cancer Diagnosis Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Non-invasive Cancer Diagnosis Market Size Market Share by Type (2017-2022)
Table 36. Europe Non-invasive Cancer Diagnosis Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Non-invasive Cancer Diagnosis Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Non-invasive Cancer Diagnosis Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Non-invasive Cancer Diagnosis Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Non-invasive Cancer Diagnosis Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Non-invasive Cancer Diagnosis
Table 45. Key Market Challenges & Risks of Non-invasive Cancer Diagnosis
Table 46. Key Industry Trends of Non-invasive Cancer Diagnosis
Table 47. Global Non-invasive Cancer Diagnosis Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Non-invasive Cancer Diagnosis Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Non-invasive Cancer Diagnosis Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Non-invasive Cancer Diagnosis Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Non-invasive Cancer Diagnosis Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Non-invasive Cancer Diagnosis Market Size Market Share Forecast by Application (2023-2028)
Table 53. Gen-Probe Inc. Details, Company Type, Non-invasive Cancer Diagnosis Area Served and Its Competitors
Table 54. Gen-Probe Inc. Non-invasive Cancer Diagnosis Product Offered
Table 55. Gen-Probe Inc. Non-invasive Cancer Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Gen-Probe Inc. Main Business
Table 57. Gen-Probe Inc. Latest Developments
Table 58. A&G Pharmaceutical Details, Company Type, Non-invasive Cancer Diagnosis Area Served and Its Competitors
Table 59. A&G Pharmaceutical Non-invasive Cancer Diagnosis Product Offered
Table 60. A&G Pharmaceutical Main Business
Table 61. A&G Pharmaceutical Non-invasive Cancer Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. A&G Pharmaceutical Latest Developments
Table 63. Affymetrix Inc. Details, Company Type, Non-invasive Cancer Diagnosis Area Served and Its Competitors
Table 64. Affymetrix Inc. Non-invasive Cancer Diagnosis Product Offered
Table 65. Affymetrix Inc. Main Business
Table 66. Affymetrix Inc. Non-invasive Cancer Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Affymetrix Inc. Latest Developments
Table 68. Digene Corporation Details, Company Type, Non-invasive Cancer Diagnosis Area Served and Its Competitors
Table 69. Digene Corporation Non-invasive Cancer Diagnosis Product Offered
Table 70. Digene Corporation Main Business
Table 71. Digene Corporation Non-invasive Cancer Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Digene Corporation Latest Developments
Table 73. Quest Diagnostics Inc. Details, Company Type, Non-invasive Cancer Diagnosis Area Served and Its Competitors
Table 74. Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Product Offered
Table 75. Quest Diagnostics Inc. Main Business
Table 76. Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Quest Diagnostics Inc. Latest Developments
Table 78. BioView Inc. Details, Company Type, Non-invasive Cancer Diagnosis Area Served and Its Competitors
Table 79. BioView Inc. Non-invasive Cancer Diagnosis Product Offered
Table 80. BioView Inc. Main Business
Table 81. BioView Inc. Non-invasive Cancer Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. BioView Inc. Latest Developments
Table 83. LabCorp Details, Company Type, Non-invasive Cancer Diagnosis Area Served and Its Competitors
Table 84. LabCorp Non-invasive Cancer Diagnosis Product Offered
Table 85. LabCorp Main Business
Table 86. LabCorp Non-invasive Cancer Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. LabCorp Latest Developments
Table 88. AVIVA Biosciences Corporation Details, Company Type, Non-invasive Cancer Diagnosis Area Served and Its Competitors
Table 89. AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Product Offered
Table 90. AVIVA Biosciences Corporation Main Business
Table 91. AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. AVIVA Biosciences Corporation Latest Developments
Table 93. Precision Therapeutics Details, Company Type, Non-invasive Cancer Diagnosis Area Served and Its Competitors
Table 94. Precision Therapeutics Non-invasive Cancer Diagnosis Product Offered
Table 95. Precision Therapeutics Main Business
Table 96. Precision Therapeutics Non-invasive Cancer Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Precision Therapeutics Latest Developments
Table 1. Non-invasive Cancer Diagnosis Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Clinical Chemistry
Table 3. Major Players of Immunochemistry/Immunoassay
Table 4. Major Players of Molecular Diagnostics
Table 5. Major Players of Others
Table 6. Non-invasive Cancer Diagnosis Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Non-invasive Cancer Diagnosis Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Non-invasive Cancer Diagnosis Market Size Market Share by Type (2017-2022)
Table 9. Non-invasive Cancer Diagnosis Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Non-invasive Cancer Diagnosis Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Non-invasive Cancer Diagnosis Market Size Market Share by Application (2017-2022)
Table 12. Global Non-invasive Cancer Diagnosis Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Non-invasive Cancer Diagnosis Revenue Market Share by Player (2020-2022)
Table 14. Non-invasive Cancer Diagnosis Key Players Head office and Products Offered
Table 15. Non-invasive Cancer Diagnosis Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Non-invasive Cancer Diagnosis Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Non-invasive Cancer Diagnosis Market Size Market Share by Regions (2017-2022)
Table 20. Americas Non-invasive Cancer Diagnosis Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Non-invasive Cancer Diagnosis Market Size Market Share by Country (2017-2022)
Table 22. Americas Non-invasive Cancer Diagnosis Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Non-invasive Cancer Diagnosis Market Size Market Share by Type (2017-2022)
Table 24. Americas Non-invasive Cancer Diagnosis Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Non-invasive Cancer Diagnosis Market Size Market Share by Application (2017-2022)
Table 26. APAC Non-invasive Cancer Diagnosis Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Non-invasive Cancer Diagnosis Market Size Market Share by Region (2017-2022)
Table 28. APAC Non-invasive Cancer Diagnosis Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Non-invasive Cancer Diagnosis Market Size Market Share by Type (2017-2022)
Table 30. APAC Non-invasive Cancer Diagnosis Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Non-invasive Cancer Diagnosis Market Size Market Share by Application (2017-2022)
Table 32. Europe Non-invasive Cancer Diagnosis Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Non-invasive Cancer Diagnosis Market Size Market Share by Country (2017-2022)
Table 34. Europe Non-invasive Cancer Diagnosis Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Non-invasive Cancer Diagnosis Market Size Market Share by Type (2017-2022)
Table 36. Europe Non-invasive Cancer Diagnosis Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Non-invasive Cancer Diagnosis Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Non-invasive Cancer Diagnosis Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Non-invasive Cancer Diagnosis Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Non-invasive Cancer Diagnosis Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Non-invasive Cancer Diagnosis
Table 45. Key Market Challenges & Risks of Non-invasive Cancer Diagnosis
Table 46. Key Industry Trends of Non-invasive Cancer Diagnosis
Table 47. Global Non-invasive Cancer Diagnosis Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Non-invasive Cancer Diagnosis Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Non-invasive Cancer Diagnosis Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Non-invasive Cancer Diagnosis Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Non-invasive Cancer Diagnosis Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Non-invasive Cancer Diagnosis Market Size Market Share Forecast by Application (2023-2028)
Table 53. Gen-Probe Inc. Details, Company Type, Non-invasive Cancer Diagnosis Area Served and Its Competitors
Table 54. Gen-Probe Inc. Non-invasive Cancer Diagnosis Product Offered
Table 55. Gen-Probe Inc. Non-invasive Cancer Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Gen-Probe Inc. Main Business
Table 57. Gen-Probe Inc. Latest Developments
Table 58. A&G Pharmaceutical Details, Company Type, Non-invasive Cancer Diagnosis Area Served and Its Competitors
Table 59. A&G Pharmaceutical Non-invasive Cancer Diagnosis Product Offered
Table 60. A&G Pharmaceutical Main Business
Table 61. A&G Pharmaceutical Non-invasive Cancer Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. A&G Pharmaceutical Latest Developments
Table 63. Affymetrix Inc. Details, Company Type, Non-invasive Cancer Diagnosis Area Served and Its Competitors
Table 64. Affymetrix Inc. Non-invasive Cancer Diagnosis Product Offered
Table 65. Affymetrix Inc. Main Business
Table 66. Affymetrix Inc. Non-invasive Cancer Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Affymetrix Inc. Latest Developments
Table 68. Digene Corporation Details, Company Type, Non-invasive Cancer Diagnosis Area Served and Its Competitors
Table 69. Digene Corporation Non-invasive Cancer Diagnosis Product Offered
Table 70. Digene Corporation Main Business
Table 71. Digene Corporation Non-invasive Cancer Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Digene Corporation Latest Developments
Table 73. Quest Diagnostics Inc. Details, Company Type, Non-invasive Cancer Diagnosis Area Served and Its Competitors
Table 74. Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Product Offered
Table 75. Quest Diagnostics Inc. Main Business
Table 76. Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Quest Diagnostics Inc. Latest Developments
Table 78. BioView Inc. Details, Company Type, Non-invasive Cancer Diagnosis Area Served and Its Competitors
Table 79. BioView Inc. Non-invasive Cancer Diagnosis Product Offered
Table 80. BioView Inc. Main Business
Table 81. BioView Inc. Non-invasive Cancer Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. BioView Inc. Latest Developments
Table 83. LabCorp Details, Company Type, Non-invasive Cancer Diagnosis Area Served and Its Competitors
Table 84. LabCorp Non-invasive Cancer Diagnosis Product Offered
Table 85. LabCorp Main Business
Table 86. LabCorp Non-invasive Cancer Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. LabCorp Latest Developments
Table 88. AVIVA Biosciences Corporation Details, Company Type, Non-invasive Cancer Diagnosis Area Served and Its Competitors
Table 89. AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Product Offered
Table 90. AVIVA Biosciences Corporation Main Business
Table 91. AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. AVIVA Biosciences Corporation Latest Developments
Table 93. Precision Therapeutics Details, Company Type, Non-invasive Cancer Diagnosis Area Served and Its Competitors
Table 94. Precision Therapeutics Non-invasive Cancer Diagnosis Product Offered
Table 95. Precision Therapeutics Main Business
Table 96. Precision Therapeutics Non-invasive Cancer Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Precision Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Non-invasive Cancer Diagnosis Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-invasive Cancer Diagnosis Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Non-invasive Cancer Diagnosis Market Size Market Share by Type in 2021
Figure 7. Non-invasive Cancer Diagnosis in Blood Cancer
Figure 8. Global Non-invasive Cancer Diagnosis Market: Blood Cancer (2017-2022) & ($ Millions)
Figure 9. Non-invasive Cancer Diagnosis in Solid Tumors
Figure 10. Global Non-invasive Cancer Diagnosis Market: Solid Tumors (2017-2022) & ($ Millions)
Figure 11. Non-invasive Cancer Diagnosis in Breast Cancer
Figure 12. Global Non-invasive Cancer Diagnosis Market: Breast Cancer (2017-2022) & ($ Millions)
Figure 13. Non-invasive Cancer Diagnosis in Lung Cancer
Figure 14. Global Non-invasive Cancer Diagnosis Market: Lung Cancer (2017-2022) & ($ Millions)
Figure 15. Non-invasive Cancer Diagnosis in Others
Figure 16. Global Non-invasive Cancer Diagnosis Market: Others (2017-2022) & ($ Millions)
Figure 17. Global Non-invasive Cancer Diagnosis Market Size Market Share by Application in 2021
Figure 18. Global Non-invasive Cancer Diagnosis Revenue Market Share by Player in 2021
Figure 19. Global Non-invasive Cancer Diagnosis Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Non-invasive Cancer Diagnosis Market Size 2017-2022 ($ Millions)
Figure 21. APAC Non-invasive Cancer Diagnosis Market Size 2017-2022 ($ Millions)
Figure 22. Europe Non-invasive Cancer Diagnosis Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Non-invasive Cancer Diagnosis Market Size 2017-2022 ($ Millions)
Figure 24. Americas Non-invasive Cancer Diagnosis Value Market Share by Country in 2021
Figure 25. Americas Non-invasive Cancer Diagnosis Consumption Market Share by Type in 2021
Figure 26. Americas Non-invasive Cancer Diagnosis Market Size Market Share by Application in 2021
Figure 27. United States Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Non-invasive Cancer Diagnosis Market Size Market Share by Region in 2021
Figure 32. APAC Non-invasive Cancer Diagnosis Market Size Market Share by Application in 2021
Figure 33. China Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Non-invasive Cancer Diagnosis Market Size Market Share by Country in 2021
Figure 40. Europe Non-invasive Cancer Diagnosis Market Size Market Share by Type in 2021
Figure 41. Europe Non-invasive Cancer Diagnosis Market Size Market Share by Application in 2021
Figure 42. Germany Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Non-invasive Cancer Diagnosis Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Non-invasive Cancer Diagnosis Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Non-invasive Cancer Diagnosis Market Size Market Share by Application in 2021
Figure 50. Egypt Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 56. APAC Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 57. Europe Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 59. United States Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 60. Canada Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 63. China Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 64. Japan Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 65. Korea Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 67. India Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 68. Australia Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 69. Germany Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 70. France Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 71. UK Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 72. Italy Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 73. Russia Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 74. Spain Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 77. Israel Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 1. Non-invasive Cancer Diagnosis Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-invasive Cancer Diagnosis Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Non-invasive Cancer Diagnosis Market Size Market Share by Type in 2021
Figure 7. Non-invasive Cancer Diagnosis in Blood Cancer
Figure 8. Global Non-invasive Cancer Diagnosis Market: Blood Cancer (2017-2022) & ($ Millions)
Figure 9. Non-invasive Cancer Diagnosis in Solid Tumors
Figure 10. Global Non-invasive Cancer Diagnosis Market: Solid Tumors (2017-2022) & ($ Millions)
Figure 11. Non-invasive Cancer Diagnosis in Breast Cancer
Figure 12. Global Non-invasive Cancer Diagnosis Market: Breast Cancer (2017-2022) & ($ Millions)
Figure 13. Non-invasive Cancer Diagnosis in Lung Cancer
Figure 14. Global Non-invasive Cancer Diagnosis Market: Lung Cancer (2017-2022) & ($ Millions)
Figure 15. Non-invasive Cancer Diagnosis in Others
Figure 16. Global Non-invasive Cancer Diagnosis Market: Others (2017-2022) & ($ Millions)
Figure 17. Global Non-invasive Cancer Diagnosis Market Size Market Share by Application in 2021
Figure 18. Global Non-invasive Cancer Diagnosis Revenue Market Share by Player in 2021
Figure 19. Global Non-invasive Cancer Diagnosis Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Non-invasive Cancer Diagnosis Market Size 2017-2022 ($ Millions)
Figure 21. APAC Non-invasive Cancer Diagnosis Market Size 2017-2022 ($ Millions)
Figure 22. Europe Non-invasive Cancer Diagnosis Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Non-invasive Cancer Diagnosis Market Size 2017-2022 ($ Millions)
Figure 24. Americas Non-invasive Cancer Diagnosis Value Market Share by Country in 2021
Figure 25. Americas Non-invasive Cancer Diagnosis Consumption Market Share by Type in 2021
Figure 26. Americas Non-invasive Cancer Diagnosis Market Size Market Share by Application in 2021
Figure 27. United States Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Non-invasive Cancer Diagnosis Market Size Market Share by Region in 2021
Figure 32. APAC Non-invasive Cancer Diagnosis Market Size Market Share by Application in 2021
Figure 33. China Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Non-invasive Cancer Diagnosis Market Size Market Share by Country in 2021
Figure 40. Europe Non-invasive Cancer Diagnosis Market Size Market Share by Type in 2021
Figure 41. Europe Non-invasive Cancer Diagnosis Market Size Market Share by Application in 2021
Figure 42. Germany Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Non-invasive Cancer Diagnosis Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Non-invasive Cancer Diagnosis Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Non-invasive Cancer Diagnosis Market Size Market Share by Application in 2021
Figure 50. Egypt Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Non-invasive Cancer Diagnosis Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 56. APAC Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 57. Europe Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 59. United States Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 60. Canada Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 63. China Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 64. Japan Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 65. Korea Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 67. India Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 68. Australia Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 69. Germany Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 70. France Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 71. UK Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 72. Italy Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 73. Russia Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 74. Spain Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 77. Israel Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Non-invasive Cancer Diagnosis Market Size 2023-2028 ($ Millions)